ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy

Maturitas

Volumn 54, Issue 2, 2006, Pages 119-126

  Almeida, Silvana ^a   Fiegenbaum, Marilu ^a   de Andrade, Fabiana M ^a   Osório Wender, Maria C ^b   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Apolipoprotein E gene; Estrogen; Estrogen receptor 1 gene; Hormonal replacement therapy; Lipid levels

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CHOLESTEROL; ESTROGEN; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN RECEPTOR 1 GENE; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; HAPLOTYPES; HUMANS; LIPIDS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 33646154652     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.09.009     Document Type: Article

References (45)

1. Benagiano G., and Farris M. Why a consensus conference on hormone replacement therapy and the cardiovascular system?. Maturitas 47 (2004) 245-253
2. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000. Fertil Steril 75 (2001) 898-915
3. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340 (1999) 1801-1811
4. Maas A.H., van der Schouw Y.T., Grobbee D.E., and van der Graaf Y. Rise and fall of hormone therapy in postmenopausal women with cardiovascular disease. Menopause 11 (2004) 228-235
5. Somekawa Y., and Wakabayashi A. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol 79 (1998) 185-191
6. Garry P.J., Baumgartner R.N., Brodie S.G., et al. Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem 45 (1999) 1214-1223
7. Heikkinen A.M., Niskanen L., Ryynanen M., et al. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?. Arterioscler Thromb Vasc Biol 19 (1999) 402-407
8. Tolosa M., Peiro S., Real J.T., Cano A., Ascaso J.F., and Carmena R. The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause. Maturitas 40 (2001) 173-181
9. Tsuda M., Sanada M., Nakagawa H., Kodama I., Sakashita T., and Ohama K. Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy. Maturitas 38 (2001) 297-304
10. Herrington D.M., Howard T.D., Hawkins G.A., et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 346 (2002) 967-974
11. von Muhlen D., Barrett-Connor E., and Kritz-Silverstein D. Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use. Atherosclerosis 161 (2002) 209-214
12. Lehtimaki T., Dastidar P., Jokela H., et al. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein E genotype. J Clin Endocrinol Metab 87 (2002) 4147-4153
13. Yamakawa-Kobayashi K., Somekawa Y., Fujimura M., Tomura S., Arinami T., and Hamaguchi H. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy. Atherosclerosis 162 (2002) 17-21
14. Nordström P., Glader C.A., Dahlen G., et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med 254 (2003) 140-146
15. Fan Y.-M., Dastidar P., Jokela H., Punnonen R., and Lehtimäki. T. review: Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women. J Clin Endocrinol Metab 90 (2005) 3786-3792
16. Koivu T.A., Fan Y.-M., Mattila K.M., et al. The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women. Maturitas 44 (2003) 29-38
17. Kamboh M.I., Aston C.E., Ferrell R.E., and Hamman R.F. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low-density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 98 (1993) 201-211
18. Mahley R.W., and Rall Jr. S.C. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1 (2000) 507-537
19. Ilveskoski E., Perola M., Lehtimäki T., et al. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men. An autopsy study. Circulation 100 (1999) 608-613
20. Viiri L.E., Loimaala A., Nenonen A., et al. The association of apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 179 (2005) 161-167
21. Srivastava R.A., Srivastava N., Averna M., et al. Estrogen up-regulates apolipoprotein E (APOE) gene expression by increasing APOE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem 272 (1997) 33360-33366
22. Schaefer E.J., Lamon-Fava S., Johnson S., et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study. Arterioscler Thromb 14 (1994) 1105-1113
23. Hak A.E., Witteman J.C., Hugens W., et al. The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis 175 (2004) 169-176
24. Karas R.H., Patterson B.L., and Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 89 (1994) 1943-1950
25. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., and Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89 (1994) 1501-1510
26. Venkov C.D., Rankin A.B., and Vaughan D.E. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation 94 (1996) 727-733
27. Lamon-Fava S. Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line Hep G2. J Nutr 130 (2000) 2489-2492
28. Lehtimäki T., Kunnas T.A., Mattila K.M., et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor1 gene polymorphism: an autopsy study. J Mol Med 80 (2002) 176-180
29. Almeida S., Franken N., Zandoná M.R., Osório-Wender M.C., and Hutz M.H. Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status. Pharmacogenomics J 5 (2005) 30-34
30. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-1201.
31. Friedwald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
32. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
33. Andersen T.I., Heimdal K.R., Skrede M., Tveit K., Berg K., and Borresen A.L. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum Genet 94 (1994) 665-670
34. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., and Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11 (1996) 306-311
35. Yaich L., Dupont W.D., Cavener D.R., and Parl F.F. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 52 (1992) 77-83
36. de-Andrade F.M., Larrandaburu M., Callegari-Jacques S.M., Gastaldo G., and Hutz M.H. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population. Braz J Med Biol Res 33 (2000) 529-537
37. Lu H., Higashikata T., Inazu A., et al. Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 22 (2002) 817-823
38. Long J.C., Williams R.C., and Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56 (1995) 799-810
39. Long JC. Multiple locus haplotype analysis, version 2.0. Software and documentation distributed by the author. Section on population genetics and linkage, Bethesda, MD: Laboratory of Neurogenetics, niaaa, National Institutes of Health; 1999.
40. Peterson R.J., Goldman D., and Long J.C. Effects of worldwide population subdivision on ALDH2 linkage disequilibrium. Genome Res 9 (1999) 844-852
41. Schneider S, Kueffer J-M, Roessli D, Excoffier L. Arlequin ver 2.000: a software for population data analysis. Geneva: Genetics and Biometry Laboratory, University of Geneva; 2000.
42. Vandevyver C., Vanhoof J., Declerck K., et al. Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. J Bone Miner Res 14 (1999) 1576-1582
43. Weel A.E., Uitterlinden A.G., Westendorp I.C., et al. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J Clin Endocrinol Metab 84 (1999) 3146-3150
44. Deng H.W., Li J., Li J.L., et al. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab 85 (2000) 2748-2751
45. Matsubara Y., Murata M., Kawano K., et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17 (1997) 3006-3012